awmsg logo



ciprofloxacin (Cetraxal®)


Reference No. 1343


Appraisal information

ciprofloxacin (Cetraxal®) 2 mg/ml ear drops


Company: Aspire Pharma Ltd
BNF category: Ear, nose and oropharynx
NMG meeting date: 16/05/2018
AWMSG meeting date: 18/07/2018
   
   
Submission Type: Limited Submission
Status: In progress
Advice No: Not available
Ratification by Welsh Government: Not available

Current Progress


Submission
received
NMG
meeting
AWMSG
meeting
Ratification by
Welsh Government

Indication

Treatment of acute otitis externa in adults and children older than 1 year with an intact tympanic membrane, caused by ciprofloxacin susceptible microorganisms
Preliminary Appraisal Recommendation (PAR)
Download
Company Response to the Preliminary Appraisal Recommendation (CR PAR)
Download
AWMSG Secretariat Appraisal Report (ASAR)
Download